在帕金森病中,UQCRC1缺乏通过PINK1依赖机制损害了线粒
Jeng-Lin Li1,2, Shu-Yi Huang3, Po-Yu Huang4,5
1Department of Neurology, National Taiwan University Hospital, Jin-Shan Branch, New Taipei, Taiwan.
NPJ Parkinson's disease
|January 15, 2026
概括
缺乏UQCRC1会导致氧化应激,并损害线粒,导致帕金森病 (PD). 准PINK1在治疗UQCRC1相关的PD方面表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 的发病与氧化酸化 (OXPHOS) 和线粒细胞衰变的缺陷有关.
- 线粒体复合体III子单元UQCRC1是一种家族性PD基因,导致OXPHOS压力,但其在异常性PD和线粒细胞衰变中的作用尚不清楚.
研究的目的:
- 调查UQCRC1在异形病性PD和线粒细胞衰变中的作用.
- 确定UQCRC1缺陷是否有助于PD的发病.
- 确定UQCRC1相关PD的潜在治疗点.
主要方法:
- 从PD和对照病例中对死后黑色物质中UQCRC1mRNA水平的元分析.
- 利用SH-SY5Y细胞和飞行模型来研究UQCRC1突变/耗尽对线粒的影响.
- 评估了PINK1和UQCRC1缺陷之间的关联.
- 测试了PINK1激活剂 (kinetin,MTK458) 的保护作用.
主要成果:
- 在特异性PD病例中观察到减少UQCRC1mRNA表达,这表明生物标志物的潜力.
- 在细胞和模型中,UQCRC1突变或枯竭损害了线粒.
- PINK1 缺乏与 UQCRC1 缺乏相关.
- 过度表达PINK1和PINK1激活剂治疗挽救了线粒和运动缺陷.
结论:
- 由UQCRC1缺乏引起的OXPHOS压力是帕金森病中线粒缺陷的病因.
- PINK1是UQCRC1相关PD的潜在治疗标.
- UQCRC1可能作为异常病理性PD的生物标志物.
相关概念视频
Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Translocation of Proteins into the Mitochondria
12.4K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
12.4K
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Electron Transport Chain: Complex I and II
18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.5K


